Director, AI & Enterprise Product Delivery

Pfizer Inc; New York (NY); Ibrido; USD 189.000 - 315.000; Tempo pieno

Vantaggi offerti da questo lavoro

401(k) matching

Retirement contributions

Paid time off

Caregiver leave

Medical, dental, vision

Descrizione del lavoro

Pfizer Inc. in New York (US) seeks a Delivery Lead – Director of AI and Product Management to drive end‑to‑end delivery for Pfizer Patient Services initiatives. You will align business needs with technology roadmaps, manage a portfolio of projects, and influence vendor strategies to accelerate value delivery.

The role requires 8+ years in IT leadership with a deep background in Salesforce, cloud, DevOps, and cybersecurity. This hybrid, on‑site position targets Pfizer’s U.S.

Competenze

• Bachelor's degree required; advanced degree preferred.
• 8+ years IT leadership in pharma/healthcare or related field.
• Proven experience with modern technology platforms (Salesforce, cloud, DevOps, cybersecurity).

Mansioni

• Own planning, delivery and support for all projects across patient support platforms.
• Lead portfolio across disease areas and teams with a multi‑year roadmap.
• Build strategic partnerships with senior leaders and stakeholders.
• Manage budgets, governance, and vendor performance.

Conoscenze

Strategic leadership

Stakeholder management

Program governance

People leadership

SDLC

Agile methodologies

Communication

Executive influence

Formazione

Bachelor's degree

Advanced degree preferred

Info Mgmt / CS / Eng / Tech Mgmt

Strumenti

Salesforce

Cloud ecosystems

DevOps

Cybersecurity

Descrizione del lavoro

Pfizer Inc. in New York (US) seeks a Delivery Lead – Director of AI and Product Management to drive end‑to‑end delivery for Pfizer Patient Services initiatives. You will align business needs with technology roadmaps, manage a portfolio of projects, and influence vendor strategies to accelerate value delivery.

The role requires 8+ years in IT leadership with a deep background in Salesforce, cloud, DevOps, and cybersecurity. This hybrid, on‑site position targets Pfizer’s U.S.